Logo new.jpg
Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)
31. Mai 2018 06:00 ET | Vivos Inc.
Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...
Logo new.jpg
Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats
01. Mai 2018 09:00 ET | Vivos Inc.
  Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma.     Five cats were treated at Washington...
LOGO.jpg
Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board
20. März 2018 09:30 ET | Vivos Inc.
Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board.    Tariq Shah BSc. DipMS is the...
Logo new
Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy
30. Januar 2018 09:00 ET | Vivos Inc.
Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the   FDA that RadioGel™ is classified as a device for animal therapy. ...
LOGO.jpg
Advanced Medical Isotope Corporation (ADMD) Refines Strategy to Accelerate Penetration of Veterinary Market
17. November 2017 06:45 ET | Advanced Medical Isotope Corporation
RICHLAND, WA, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late-stage radiation oncology-focused medical device company, is initially focusing its...